Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$619M |
| 2 |
Citigroup
C
|
+$457M |
| 3 |
Cimpress
CMPR
|
+$379M |
| 4 |
Broadcom
AVGO
|
+$374M |
| 5 |
Apple
AAPL
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$331M |
| 3 |
IQVIA
IQV
|
+$243M |
| 4 |
Costco
COST
|
+$193M |
| 5 |
St. Joe Company
JOE
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.77% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATH
1226
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $578K | ﹤0.01% |
10,744
-89,256
| -89% | -$4.62M |
|
|
CHCT
1227
Community Healthcare Trust
CHCT
$537M
| $570K | ﹤0.01% |
21,150
| – | – |
|
1228
ING
ING
$93.8B
| $555K | ﹤0.01% |
30,108
| – | – |
|
|
MPT
1229
Medical Properties Trust
MPT
$2.89B
| $552K | ﹤0.01% |
42,058
+31,468
| +297% | +$405K |
|
|
ITCI
1230
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $552K | ﹤0.01% |
35,000
| – | – |
|
1231
Empire State Realty Trust
ESRT
$976M
| $547K | ﹤0.01% |
26,630
-348,933
| -93% | -$7.15M |
|
1232
Timken Company
TKR
$9.82B
| $493K | ﹤0.01% |
10,156
+5,500
| +118% | +$254K |
|
1233
Charles River Laboratories
CRL
$10.9B
| $454K | ﹤0.01% |
+4,200
| New | +$431K |
|
1234
Diageo
DEO
$46.2B
| $448K | ﹤0.01% |
3,392
| – | – |
|
1235
Pegasystems
PEGA
$4.41B
| $443K | ﹤0.01% |
15,352
+1,310
| +9% | +$37.9K |
|
1236
iShares MSCI Canada ETF
EWC
$6.04B
| $442K | ﹤0.01% |
15,275
-47,153
| -76% | -$1.31M |
|
1237
Ubiquiti
UI
$31.8B
| $428K | ﹤0.01% |
7,635
-223
| -3% | -$12.8K |
|
|
QCP
1238
DELISTED
Quality Care Properties, Inc.
QCP
| $428K | ﹤0.01% |
27,618
+11,718
| +74% | +$186K |
|
1239
Dick's Sporting Goods
DKS
$18.4B
| $427K | ﹤0.01% |
15,800
-8,685
| -35% | -$276K |
|
|
LMRK
1240
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $426K | ﹤0.01% |
+25,159
| New | +$422K |
|
|
SVC
1241
Service Properties Trust
SVC
$1.1B
| $425K | ﹤0.01% |
2,986
-9,140
| -75% | -$1.29M |
|
|
ORAN
1242
DELISTED
Orange
ORAN
| $422K | ﹤0.01% |
25,757
| – | – |
|
1243
Burlington
BURL
$22B
| $415K | ﹤0.01% |
4,348
-10,038
| -70% | -$881K |
|
|
DST
1244
DELISTED
DST Systems Inc.
DST
| $412K | ﹤0.01% |
7,500
-24,700
| -77% | -$1.35M |
|
1245
AutoNation
AN
$6.97B
| $393K | ﹤0.01% |
8,272
+1,600
| +24% | +$69.3K |
|
|
LM
1246
DELISTED
Legg Mason, Inc.
LM
| $389K | ﹤0.01% |
+9,900
| New | +$380K |
|
|
VSM
1247
DELISTED
Versum Materials, Inc.
VSM
| $388K | ﹤0.01% |
+10,000
| New | +$358K |
|
1248
Prudential
PUK
$36.5B
| $382K | ﹤0.01% |
8,214
| – | – |
|
1249
National Fuel Gas
NFG
$7.84B
| $380K | ﹤0.01% |
6,710
-6,700
| -50% | -$388K |
|
|
STMP
1250
DELISTED
Stamps.com, Inc.
STMP
| $356K | ﹤0.01% |
1,757
+97
| +6% | +$17.8K |
|
Similar funds
Janus Henderson Group's Q3 2017 Portfolio in Review
As of Q3 2017, Janus Henderson Group held 1,386 positions worth $156B, up 5.9% from $147B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q3 2017 filing shows 78 new, 598 increased, 569 reduced and 102 closed positions. Its largest new stake was Medtronic: 7,457,362 shares worth $580M. The largest sale was Reynolds American Inc, an estimated $348M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2017 buy was Medtronic: 7,457,362 shares worth $580M.
- Janus Henderson Group added most to Citigroup in Q3 2017, an estimated $457M increase.
- Janus Henderson Group's biggest Q3 2017 reduction was Microsoft, cutting an estimated $331M.
- Janus Henderson Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $348M.
- Janus Henderson Group's ten largest holdings make up 14% of its $156B portfolio in Q3 2017.
- Janus Henderson Group opened 78 new positions and closed 102 in Q3 2017.
- Janus Henderson Group's portfolio value rose 5.9% quarter-over-quarter to $156B.
Based on Janus Henderson Group's 13F filing for Q3 2017, filed 14 Nov 2017.